Refractory Chronic Lymphocytic Leukemia

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Duarte, California
  • +2 more
Oct 7, 2022

Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

Completed
  • Anemia
  • +13 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 29, 2021

Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 15, 2021

Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
Jan 17, 2020

Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +29 more
  • Fludarabine Phosphate
  • +5 more
  • Tucson, Arizona
  • +9 more
Dec 18, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014